Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ESCC”

263 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 263 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06508229
What this trial is testing

Adebrelimab Combined With Albumin Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Resectable ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Harbin Medical University 65
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07584031
What this trial is testing

Adebrelimab Plus Full-course Neoadjuvant Therapy for Resectable Locally Advanced ESCC (Phase 2)

Who this might be right for
ESCC
Tianjin Medical University Cancer Institute and Hospital 200
Testing effectiveness (Phase 2)Looking for participantsNCT06452602
What this trial is testing

Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy in Patients With ESCC.

Who this might be right for
Esophageal Cancer
Tianjin Medical University Cancer Institute and Hospital 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07618910
What this trial is testing

Retlirafusp Alfa Plus Chemotherapy as Neoadjuvant Therapy for Thoracic ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Tang-Du Hospital 33
Testing effectiveness (Phase 2)Looking for participantsNCT07385001
What this trial is testing

A Prospective, Multicenter, Phase Ib/II Trial of Ivonescimab (AK112) Combined With Albumin-Paclitaxel and Cisplatin as Neoadjuvant Therapy for ESCC

Who this might be right for
Esophageal Squamous Cell CarcinomaIvonescimabNeoadjuvant
Tang-Du Hospital 45
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07701681
What this trial is testing

Sacituzumab Tirumotecan (Sac-TMT/SKB264) Plus Tagitanlimab (KL-A167) in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma and Gastric/Gastroesophageal Junction Adenocarcinoma

Who this might be right for
ESCCGastric AdenocarcinomaGastroesophageal Junction Adenocarcinoma+2 more
Sun Yat-sen University 75
Testing effectiveness (Phase 2)Looking for participantsNCT06122493
What this trial is testing

Optimization of Treatment Strategy for Unresectable cN3 Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Ruijin Hospital 48
Testing effectiveness (Phase 2)UnknownNCT05791136
What this trial is testing

Immunotherapy After Radiotherapy in Elderly ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma by AJCC V8 Stage
The Central Hospital of Lishui City 30
Testing effectiveness (Phase 2)UnknownNCT06186609
What this trial is testing

PD-1 Inhibitor Combined With Radiotherapy for Elderly ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
Affiliated Hospital of Nantong University 68
Not applicableNot Yet RecruitingNCT07388095
What this trial is testing

Adebrelimab Neoadjuvant Treatment for Resectable ESCC

Who this might be right for
ESCC
Tianjin Medical University Cancer Institute and Hospital 22
Large-scale testing (Phase 3)Looking for participantsNCT07177794
What this trial is testing

Consolidation of Toripalimab and Capecitabine After Chemoradiotherapy in ESCC

Who this might be right for
Esophageal CancerChemoradiotherapy
Sun Yat-sen University 242
Not applicableNot Yet RecruitingNCT07353541
What this trial is testing

Standardized Management of Esophageal Fistula in Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)Esophageal Fistula
Peking University Cancer Hospital & Institute 32
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07533305
What this trial is testing

Efficacy and Safety of QL1706 Combined With Nab-paclitaxel and Cisplatin as 1st Line Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
QL1706ESCCFirst-line Therapy
The First Affiliated Hospital of Henan University of Science and Technology 50
Not applicableStudy completedNCT07549269
What this trial is testing

Comparison of Nab-Paclitaxel Versus Paclitaxel in Neoadjuvant Immunochemotherapy Therapy for Esophageal Squamous Cell Carcinoma: A Retrospective IPTW-Adjusted Analysis

Who this might be right for
Esophageal Cancer
Sichuan University 387
Testing effectiveness (Phase 2)UnknownNCT04863079
What this trial is testing

Pembrolizumab in Post Radical Operation ESCC Patients With Lymph Node Positive ( KEYSTONE-004 )

Who this might be right for
ESCCAdjuvant TreatmentLymph Node Positive+1 more
Tianjin Medical University Cancer Institute and Hospital 82
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07272291
What this trial is testing

A Phase II Study of Toripalimab Plus Chemotherapy and Low-Dose Radiotherapy for Neoadjuvant Therapy-Refractory Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Tianjin Medical University Cancer Institute and Hospital 48
Not applicableStudy completedNCT03001596
What this trial is testing

Comparison Between NCRT and NCT Followed by MIE for Treatment of Locally Advanced Resectable ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma Stage cT3-4aN0-1M0
Shanghai Zhongshan Hospital 264
Post-approval studies (Phase 4)Ended earlyNCT02721576
What this trial is testing

A Trial of CMNa Combined With Concurrent Chemoradiotherapy for Locally Recurrent ESCC

Who this might be right for
Esophageal Neoplasms
Shandong Cancer Hospital and Institute 8
Early research (Phase 1)Study completedNCT01822613
What this trial is testing

Study of Safety & Efficacy of the Combination of LJM716 & BYL719 in Patients With Previously Treated Esophageal Squamous Cell Carcinoma (ESCC)

Who this might be right for
Esophageal Squamous Cell Carcinoma
Novartis Pharmaceuticals 48
Not applicableUnknownNCT04471480
What this trial is testing

TC Plus PD-1 Inhibitors Combined With Anlotinib for Advanced Advanced Esophageal Cancer

Who this might be right for
ESCC
Dong Wang 90
Next Page